Abstract:Selective incorporation of deuterium atoms into molecules is of high interest for labeling purposes and for optimizing properties of drug candidates. A mild and environmentally benign method for the deuteration of alkyl iodides via radical pathway using DO as source of deuterium has been developed. The reaction is initiated and mediated by triethylborane in the presence of dodecanethiol as a catalyst. This method is compatible with a wide range of functional groups and provides the monodeuterated products in g… Show more
“…The 1 H, 13 C and 31 P NMR data of 1 suggested a dipolar structure. Particularly, the 31 P NMR spectrum showed a characteristic signal for tetravalent phosphorus at 16.7 ppm in CD 3 CN (17.9 ppm in D 2 O or DMSO-d6).…”
Section: Synthesis Of Trimethylphosphonium Phenolate Zwitterionmentioning
confidence: 99%
“…[9] Here we report a new trimethylphosphonium phenolate zwitterion 1 (Scheme 1c). [12,13] Thus a new catalytic deuteration process using 1 as the catalyst and CD 3 CN as deuterium source was revealed to selectively afford several deuterium-labelled products with high deuteration. [11] Recognizing the little knowledge on this type of products, a subsequent study was conducted to reveal the reactivity.…”
Section: Introductionmentioning
confidence: 99%
“…Notably, the development of new hydrogen isotope exchange reactions to access isotopically labeled organic molecules is of current interest in organic chemistry due to the value of deuterated compounds in the study of reaction mechanisms, mass-dependent analysis and biological processes. [12,13] Thus a new catalytic deuteration process using 1 as the catalyst and CD 3 CN as deuterium source was revealed to selectively afford several deuterium-labelled products with high deuteration. In addition, 1 also demonstrated an interesting reactivity similar to a phosphonium ylide and could be used as an olefination reagent to convert aldehydes into terminal alkenes.…”
4-Methoxy-3-(trimethylphosphonio)phenolate was obtained from a regioselective addition of PMe 3 to p-quinone monoacetal. This compound undergoes hydrogen isotope exchange with D 2 O or CD 3 CN, and is capable of catalyzing H/D exchange of CD 3 CN with substrates bearing weakly acidic hydrogens. It exhibits similar reactivity to phosphorus ylides for olefinations of aldehydes. A possible tautomerization between the phosphonium phenolate zwitterion and phosphonium ylide is proposed for the first time to rationalize the unique reactivity.
“…The 1 H, 13 C and 31 P NMR data of 1 suggested a dipolar structure. Particularly, the 31 P NMR spectrum showed a characteristic signal for tetravalent phosphorus at 16.7 ppm in CD 3 CN (17.9 ppm in D 2 O or DMSO-d6).…”
Section: Synthesis Of Trimethylphosphonium Phenolate Zwitterionmentioning
confidence: 99%
“…[9] Here we report a new trimethylphosphonium phenolate zwitterion 1 (Scheme 1c). [12,13] Thus a new catalytic deuteration process using 1 as the catalyst and CD 3 CN as deuterium source was revealed to selectively afford several deuterium-labelled products with high deuteration. [11] Recognizing the little knowledge on this type of products, a subsequent study was conducted to reveal the reactivity.…”
Section: Introductionmentioning
confidence: 99%
“…Notably, the development of new hydrogen isotope exchange reactions to access isotopically labeled organic molecules is of current interest in organic chemistry due to the value of deuterated compounds in the study of reaction mechanisms, mass-dependent analysis and biological processes. [12,13] Thus a new catalytic deuteration process using 1 as the catalyst and CD 3 CN as deuterium source was revealed to selectively afford several deuterium-labelled products with high deuteration. In addition, 1 also demonstrated an interesting reactivity similar to a phosphonium ylide and could be used as an olefination reagent to convert aldehydes into terminal alkenes.…”
4-Methoxy-3-(trimethylphosphonio)phenolate was obtained from a regioselective addition of PMe 3 to p-quinone monoacetal. This compound undergoes hydrogen isotope exchange with D 2 O or CD 3 CN, and is capable of catalyzing H/D exchange of CD 3 CN with substrates bearing weakly acidic hydrogens. It exhibits similar reactivity to phosphorus ylides for olefinations of aldehydes. A possible tautomerization between the phosphonium phenolate zwitterion and phosphonium ylide is proposed for the first time to rationalize the unique reactivity.
“…Site‐specific incorporation of deuterium is important since deuterium‐labeled compounds are widely applied in synthetic and medicinal chemistry (kinetic isotope effect measurements, pharmacokinetic and pharmacodynamics research) . Radical deuteration using D 2 O as the D‐source represents a promising approach due to the low cost of D 2 O and the high functional group tolerance of radical chemistry. Recently, MacMillan and Renaud developed radical deuterations with D 2 O as the formal D‐donor using phenol or thiol type HAT‐reagents, that readily exchange their protons with D 2 O.…”
The diversity‐oriented desulfonylative functionalization of alkyl allyl sulfones with various sulfone‐type reagents by radical chemistry has been developed. The readily installed allylsulfonyl moiety acts as a C‐radical precursor, which is substituted by various functionalities using sulfur‐based radical trapping reagents. The generality of this approach is documented by the successful desulfonylative alkynylation, azidation, trifluoromethylthiolation, sulfenylation, trifluoromethylselenylation, halogenation, and deuteration. The method is compatible with a wide range of functional groups. Considering the deuteration, products are obtained in good yields with a high level of deuterium incorporation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.